Zai Lab (ZLAB) Cash from Financing Activities (2018 - 2026)

Zai Lab (ZLAB) posted quarterly Cash from Financing Activities of $5.6 million for Q1 2026, down 87.08% year-on-year from $43.1 million in Q1 2025, and up 1396.05% on a QoQ basis from -$430000.0 in Q4 2025.

Zai Lab (ZLAB) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Cash from Financing Activities for 9 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Financing Activities fell 87.08% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.8 million (down 89.93% YoY) and the FY2025 annual result came in at $72.4 million, down 79.32% from the prior year.
  • Cash from Financing Activities rose to $5.6 million in Q1 2026 per ZLAB's latest filing, from -$430000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ZLAB reached as high as $237.8 million in Q4 2024 and fell as low as -$3.9 million in Q1 2023.
  • A 5-year average of $24.7 million and a median of $709000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 1606.2% — and 2024, when it soared 60411.96%.
  • Year by year, Cash from Financing Activities stood at -$199000.0 in 2022, then surged by 297.49% to $393000.0 in 2023, then surged by 60411.96% to $237.8 million in 2024, then plunged by 100.18% to -$430000.0 in 2025, then jumped by 1396.05% to $5.6 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $5.6 million, -$430000.0, and $20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 5.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.57 Mn
Mar 31, 2026 5.57 Mn
Dec 31, 2025 -430,000.00
Dec 31, 2025 -430,000.00
Sep 30, 2025 20.79 Mn
Sep 30, 2025 20.79 Mn
Jun 30, 2025 8.85 Mn
Jun 30, 2025 8.85 Mn
Mar 31, 2025 43.14 Mn
Mar 31, 2025 43.14 Mn
Dec 31, 2024 237.81 Mn
Dec 31, 2024 237.81 Mn
Sep 30, 2024 42.21 Mn
Sep 30, 2024 42.21 Mn
Jun 30, 2024 22.32 Mn
Jun 30, 2024 22.32 Mn
Mar 31, 2024 47.55 Mn
Mar 31, 2024 47.55 Mn
Dec 31, 2023 393,000.00
Dec 31, 2023 393,000.00